Preparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapy

Theranostics

Volumn 2, Issue 7, 2012, Pages 681-694

  Yong, Ken Tye ^a   Wang, Yucheng ^a   Roy, Indrajit ^b   Rui, Hu ^a   Swihart, Mark T ^c   Law, Wing Cheung ^d   Kwak, Sang Kyu ^e   Ye, Ling ^f   Liu, Jianwei ^f   Mahajan, Supriya D ^d   Reynolds, Jessica L ^d  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b UNIVERSITY OF DELHI   (India)

^c State University of New York   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e Nanyang Technological University   (Singapore)

^f CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Drug nanoparticle formulations; Quantum dots; Targeted delivery

Indexed keywords

CADMIUM SELENIDE; DAUNORUBICIN; DOXORUBICIN; FLUOROURACIL; QUANTUM DOT; SAQUINAVIR; SMALL INTERFERING RNA; TEMOZOLOMIDE; TRANSFERRIN RECEPTOR; ZINC OXIDE; ZINC SULFIDE;

APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CONJUGATION; CYTOTOXICITY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LUNG DISEASE; MACROPHAGE; MOLECULARLY TARGETED THERAPY; NONHUMAN; OVARY CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOTODYNAMIC THERAPY; SYNTHESIS;

EID: 84864410596     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3692     Document Type: Article

References (96)

1. Azzazy HME, Mansour MMH, Kazmierczak SC. From diagnostics to therapy: Prospects of quantum dots. Clinical Biochemistry. 2007; 40: 917-27.
2. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, et al. Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics. Science. 2005; 307: 538-44. doi:10.1126/science.1104274.
3. Prasad PN. Nanophotonics. New York: Wiley-Interscience. 2004.
4. Prasad PN. Biophotonics. New York: Wiley-Interscience. 2004.
5. Farokhzad OC, Langer R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities. Advanced Drug Delivery Reviews. 2006; 58: 1456-9.
6. Harris TJ, Green JJ, Fung PW, Langer R, Anderson DG, Bhatia SN. Tissue-specific gene delivery via nanoparticle coating. Biomaterials. 2010; 31: 998-1006. doi: 10.1016/j.biomaterials.2009.10.012.
7. Bonoiu A, Mahajan SD, Ye L, Kumar R, Ding H, Yong K-T, et al. MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Research. 2009; 1282: 142-55. doi: 10.1016/j.brainres.2009.05.047.
8. Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications. Nano Letters. 2010; 10: 3223-30. doi:10.1021/nl102184c.
9. Karnik R, Gu F, Basto P, Cannizzaro C, Dean L, Kyei-Manu W, et al. Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles. Nano Letters. 2008; 8: 2906-12. doi:10.1021/nl801736q.
10. Kost J, Langer R. Responsive polymeric delivery systems. Advanced Drug Delivery Reviews. 2001; 46: 125-48. doi: 10.1016/s0169-409x(00)00136-8.
11. Joseph K, Robert L. Responsive polymeric delivery systems. Advanced Drug Delivery Reviews. 2001;6: 19-50. doi: 10.1016/0169-409x(91)90030-g.
12. Alexis F, Rhee J-W, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. New frontiers in nanotechnology for cancer treatment. Urologic Oncology: Seminars and Original Investigations. 2008;26: 74-85. doi: 10.1016/j.urolonc.2007.03.017.
13. Chan JM, Zhang L, Yuet KP, Liao G, Rhee J-W, Langer R, et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials. 2009; 30: 1627-34. doi: 10.1016/j.biomaterials.2008.12.013.
14. Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC. Nanotechnology and aptamers: applications in drug delivery. Trends in Biotechnology. 2008; 26: 442-9. doi: 10.1016/j.tibtech.2008.04.006.
15. Langer R. Transdermal drug delivery: past progress, current status, and future prospects. Advanced Drug Delivery Reviews. 2004; 56: 557-8. doi: 10.1016/j.addr.2003.10.021.
16. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 2007; 28: 869-76. doi: 10.1016/j.biomaterials.2006.09.047.
17. Moses MA, Brem H, Langer R. Advancing the field of drug delivery: Taking aim at cancer. Cancer Cell. 2003; 4: 337-41. doi: 10.1016/s1535-6108(03)00276-9.
18. Langer R. Polymer implants for drug delivery in the brain. Journal of Controlled Release. 1991;16: 53-9. doi: 10.1016/0168-3659(91)90030-h.
19. Farokhzad OC, Langer R. Impact of Nanotechnology on Drug Delivery. ACS Nano. 2009; 3: 16-20. doi:10.1021/nn900002m.
20. Valencia PM, Basto PA, Zhang L, Rhee M, Langer R, Farokhzad OC, et al. Single-Step Assembly of Homogenous Lipid-Polymeric and Lipid-Quantum Dot Nanoparticles Enabled by Microfluidic Rapid Mixing. ACS Nano. 2010; 4: 1671-9. doi:10.1021/nn901433u.
21. Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I, Kaur N, et al. Organically modified silica nanoparticles: A nonviral vector for in vivo gene delivery and expression in the brain. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102: 11539-44. doi:10.1073/pnas.0504926102.
22. Ding H, Yong KT, Roy I, Pudavar HE, Law WC, Bergey EJ, et al. Gold Nanorods Coated with Multilayer Polyelectrolyte as Contrast Agents for Multimodal Imaging. J Phys Chem C. 2007; 111: 12552-7.
23. El-Sayed IH, Huang X, El-Sayed MA. Surface Plasmon Resonance Scattering and Absorption of anti-EGFR Antibody Conjugated Gold Nanoparticles in Cancer Diagnostics: Applications in Oral Cancer. Nano Lett. 2005; 5: 829-34.
24. Ballou B, Ernst LA, Andreko S, Harper T, Fitzpatrick JAJ, Waggoner AS, et al. Sentinel Lymph Node Imaging Using Quantum Dots in Mouse Tumor Models. Bioconjugate Chemistry. 2007; 18: 389-96.
25. Ozkan M. Quantum dots and other nanoparticles: what can they offer to drug discovery? Drug Discovery Today. 2004; 9: 1065-71. doi: 10.1016/s1359-6446(04)03291-x.
26. Shi C, Zhu Y, Cerwinka WH, Zhau HE, Marshall FF, Simons JW, et al. Quantum Dots: Emerging applications in urologic oncology. Urologic Oncology: Seminars and Original Investigations. 2008;26: 86-92. doi: 10.1016/j.urolonc.2007.03.018.
27. Wang C-H, Hsu Y-S, Peng C-A. Quantum dots encapsulated with amphiphilic alginate as bioprobe for fast screening anti-dengue virus agents. Biosensors and Bioelectronics. 2008; 24: 1012-9. doi: 10.1016/j.bios.2008.08.009.
28. Byers RJ, Hitchman ER. Quantum Dots Brighten Biological Imaging. Progress in Histochemistry and Cytochemistry. 2011; 45: 201-37. doi: 10.1016/j.proghi.2010.11.001.
29. Hasegawa U, Nomura S-iM, Kaul SC, Hirano T, Akiyoshi K. Nanogel-quantum dot hybrid nanoparticles for live cell imaging. Biochemical and Biophysical Research Communications. 2005; 331: 917-21. doi: 10.1016/j.bbrc.2005.03.228.
30. Yang K, Cao Y-A, Shi C, Li Z-G, Zhang F-J, Yang J, et al. Quantum dot-based visual in vivo imaging for oral squamous cell carcinoma in mice. Oral Oncology. 2010; 46: 864-8. doi: 10.1016/j.oraloncology.2010.09.009.
31. Yukawa H, Kagami Y, Watanabe M, Oishi K, Miyamoto Y, Okamoto Y, et al. Quantum dots labeling using octa-arginine peptides for imaging of adipose tissue-derived stem cells. Biomaterials. 2010; 31: 4094-103. doi: 10.1016/j.biomaterials.2010.01.134.
32. Juzenas P, Chen W, Sun Y-P, Coelho MAN, Generalov R, Generalova N, et al. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Advanced Drug Delivery Reviews. 2008; 60: 1600-14. doi: 10.1016/j.addr.2008.08.004.
33. Smith AM, Duan H, Mohs AM, Nie S. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Advanced Drug Delivery Reviews. 2008; 60: 1226-40. doi: 10.1016/j.addr.2008.03.015.
34. Praetner M, Rehberg M, Bihari P, Lerchenberger M, Uhl B, Holzer M, et al. The contribution of the capillary endothelium to blood clearance and tissue deposition of anionic quantum dots in vivo. Biomaterials. 2010; 31: 6692-700. doi: 10.1016/j.biomaterials.2010.05.051.
35. Rousserie G, Sukhanova A, Even-Desrumeaux K, Fleury F, Chames P, Baty D, et al. Semiconductor quantum dots for multiplexed bio-detection on solid-state microarrays. Critical Reviews in Oncology/Hematology. 2010; 74: 1-15. doi: 10.1016/j.critrevonc.2009.04.006.
36. Russ Algar W, Krull UJ. Characterization of the adsorption of oligonucleotides on mercaptopropionic acid-coated CdSe/ZnS quantum dots using fluorescence resonance energy transfer. Journal of Colloid and Interface Science. 2011; 359: 148-54. doi: 10.1016/j.jcis.2011.03.058.
37. Bharali DJ, Lucey DW, Jayakumar H, Pudavar HE, Prasad PN. Folate-receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy. J Am Chem Soc. 2005; 127: 11364-71.
38. Gao X, Cui Y, Levenson RM, Chung LWK, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotech. 2004; 22: 969-76.
39. Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, et al. Peptide-Labeled Near-Infrared Quantum Dots for Imaging Tumor Vasculature in Living Subjects. Nano Lett. 2006; 6: 669-76.
40. Yong K-T, Hu R, Roy I, Ding H, Vathy LA, Bergey EJ, et al. Tumor Targeting and Imaging in Live Animals with Functionalized Semiconductor Quantum Rods. ACS Applied Materials & Interfaces. 2009; 1: 710-9. doi:10.1021/am8002318.
41. Yong KT. Biophotonics and Biotechnology in Pancreatic Cancer: Cyclic RGD-Peptide-Conjugated Type II Quantum Dots for in vivo Imaging. Pancreatology. 2010; 10: 553-64.
42. Erogbogbo F, Yong K-T, Roy I, Hu R, Law W-C, Zhao W, et al. In Vivo Targeted Cancer Imaging, Sentinel Lymph Node Mapping and Multi-Channel Imaging with Biocompatible Silicon Nanocrystals. ACS Nano. 2010; 5: 413-23. doi:10.1021/nn1018945.
43. Erogbogbo F, Yong K-T, Hu R, Law W-C, Ding H, Chang C-W, et al. Biocompatible Magnetofluorescent Probes: Luminescent Silicon Quantum Dots Coupled with Superparamagnetic Iron(III) Oxide. ACS Nano. 2010; 4: 5131-8. doi:10.1021/nn101016f.
44. Adeli M, Hakimpoor F, Parsamanesh M, Kalantari M, Sobhani Z, Attyabi F. Quantum dot-pseudopolyrotaxane supramolecules as anticancer drug delivery systems. Polymer. 2011; doi: 10.1016/j.polymer.2011.02.032.
45. Zrazhevskiy P, Gao X. Multifunctional quantum dots for personalized medicine. Nano Today. 2009; 4: 414-28. doi: 10.1016/j.nantod.2009.07.004.
46. Dorfs D, Krahne R, Falqui A, Manna L, Giannini C, Zanchet D. Quantum Dots: Synthesis and Characterization. In: David LA, Gregory DS, Gary PW, editors. Comprehensive Nanoscience and Technology. Amsterdam: Academic Press. 2011: 219-70.
47. Mokari T, Banin U. Synthesis and Properties of CdSe/ZnS Core/Shell Nanorods. Chem Mater. 2003; 15: 3955-60.
48. Peng ZA, Peng X. Formation of High-Quality CdTe, CdSe, and CdS Nanocrystals Using CdO as Precursor. J Am Chem Soc. 2001; 123: 183-4.
49. Talapin DV, Koeppe R, Gotzinger S, Kornowski A, Lupton JM, Rogach AL, et al. Highly Emissive Colloidal CdSe/CdS Heterostructures of Mixed Dimensionality. Nano Lett. 2003; 3: 1677-81.
50. Rogach AL, Franzl T, Klar TA, Feldmann J, Gaponik N, Lesnyak V, et al. Aqueous Synthesis of Thiol-Capped CdTe Nanocrystals: State-of-the-Art. The Journal of Physical Chemistry C. 2007; 111: 14628-37. doi:10.1021/jp072463y.
51. Murray CB, Norris DJ, Bawendi MG. Synthesis and Characterization of Nearly Monodisperse CdE (E = Sulfur, Selenium, Tellurium) Semiconductor Nanocrystallites. J Am Chem Soc. 1993; 115: 8706-15.
52. Murray CB, Kagan CR, Bawendi MG. Self-Organization of CdSe Nanocrystallites into Three-Dimensional Quantum Dot Superlattices. Science. 1995; 270: 1335-8. doi:10.1126/science.270.5240.1335.
53. Peng ZA, Peng X. Nearly Monodisperse and Shape-Controlled CdSe Nanocrystals via Alternative Routes: Nucleation and Growth. J Am Chem Soc. 2002; 124: 3343-53.
54. Dabbousi BO, Rodriguez-Viejo J, Mikulec FV, Heine JR, Mattoussi H, Ober R, et al. (CdSe)ZnS Core-Shell Quantum Dots: Synthesis and Characterization of a Size Series of Highly Luminescent Nanocrystallites. J Phys Chem B. 1997; 101: 9463-75.
55. Peng X, Schlamp MC, Kadavanich AV, Alivisatos AP. Epitaxial Growth of Highly Luminescent CdSe/CdS Core/Shell Nanocrystals with Photostability and Electronic Accessibility. J Am Chem Soc. 1997; 119: 7019-29.
56. Alivisatos P. The use of nanocrystals in biological detection. Nat Biotech. 2004; 22: 47-52.
57. Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proceedings of the National Academy of Sciences. 2002; 99: 12617-21. doi:10.1073/pnas.152463399.
58. Bruchez M, Jr., Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor Nanocrystals as Fluorescent Biological Labels. Science. 1998; 281: 2013-6. doi:10.1126/science.281.5385.2013.
59. Burda C, Chen X, Narayanan R, El-Sayed MA. Chemistry and Properties of Nanocrystals of Different Shapes. Chem Rev. 2005; 105: 1025-102.
60. Chan WC, et al. Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection. Science. 1998; 281: 2016-8. doi:10.1126/science.281.5385.2016.
61. Courty S, Bouzigues C, Luccardini C, Ehrensperger M, Bonneau S, Dahan M, et al. Tracking Individual Proteins in Living Cells Using Single Quantum Dot Imaging. Methods in Enzymology. Academic Press. 2006:211-28.
62. Derfus AM, Chan WCW, Bhatia SN. Intracellular Delivery of Quantum Dots for Live Cell Labeling and Organelle Tracking. Advanced Materials. 2004; 16: 961-6.
63. Costa-Fernández JM, Pereiro R, Sanz-Medel A. The use of luminescent quantum dots for optical sensing. TrAC Trends in Analytical Chemistry. 2006; 25: 207-18.
64. Zimmer JP, Kim SW, Ohnishi S, Tanaka E, Frangioni JV, Bawendi MG. Size Series of Small Indium Arsenide-Zinc Selenide Core-Shell Nanocrystals and Their Application to In Vivo Imaging. J Am Chem Soc. 2006; 128: 2526-7.
65. Jamieson T, Bakhshi R, Petrova D, Pocock R, Imani M, Seifalian AM. Biological applications of quantum dots. Biomaterials. 2007; 28: 4717-32.
66. Dong W, Guo L, Wang M, Xu S. CdTe QDs-based prostate-specific antigen probe for human prostate cancer cell imaging. Journal of Luminescence. 2009; 129: 926-30.
67. Jiang W, Mardyani S, Fischer H, Chan CW. Design and Characterization of Lysine Cross-Linked Mercapto-Acid Biocompatible Quantum Dots. Chem Mater. 2006; 18: 872-8.
68. Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, et al. Water-Soluble Quantum Dots for Multiphoton Fluorescence Imaging in Vivo. Science. 2003; 300: 1434-6. doi:10.1126/science.1083780.
69. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles. Science. 2002; 298: 1759-62. doi:10.1126/science.1077194.
70. Erogbogbo F, Yong K-T, Roy I, Xu G, Prasad PN, Swihart MT. Biocompatible Luminescent Silicon Quantum Dots for Imaging of Cancer Cells. ACS Nano. 2008; 2: 873-8.
71. Fu A, Gu W, Boussert B, Koski K, Gerion D, Manna L, et al. Semiconductor Quantum Rods as Single Molecule Fluorescent Biological Labels. Nano Lett. 2007; 7: 179-82.
72. Liu W, Choi HS, Zimmer JP, Tanaka E, Frangioni JV, Bawendi M. Compact Cysteine-Coated CdSe(ZnCdS) Quantum Dots for in Vivo Applications. J Am Chem Soc. 2007; 129: 14530-1.
73. Gerion D, Pinaud F, Williams SC, Parak WJ, Zanchet D, Weiss S, et al. Synthesis and Properties of Biocompatible Water-Soluble Silica-Coated CdSe/ZnS Semiconductor Quantum Dots. J Phys Chem B. 2001; 105: 8861-71.
74. Duan H, Nie S. Cell-Penetrating Quantum Dots Based on Multivalent and Endosome-Disrupting Surface Coatings. Journal of the American Chemical Society. 2007; 129: 3333-8.
75. Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, Langer R, et al. Quantum Dotâ̂ ?Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer. Nano Letters. 2007; 7: 3065-70.
76. Chakravarthy KV, Davidson BA, Helinski JD, Ding H, Law W-C, Yong K-T, et al. Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation. Nanomedicine: Nanotechnology, Biology and Medicine. 2011; 7: 88-96. doi: 10.1016/j.nano.2010.09.001.
77. Mahajan SD, Roy I, Xu G, Yong K-T, Ding H, Aalinkeel R, et al. Enhancing the Delivery of Anti Retroviral Drug " Saquinavir" Across the Blood Brain Barrier Using Nanoparticles. Current HIV Research. 2010; 9: 396-404.
78. Yuan Q, Hein S, Misra RDK. New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: Synthesis, characterization and in vitro drug delivery response. Acta Biomaterialia. 2010; 6: 2732-9. doi: 10.1016/j.actbio.2010.01.025.
79. Savla R, Taratula O, Garbuzenko O, Minko T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. Journal of Controlled Release. 2011; doi: 10.1016/j.jconrel.2011.02.015.
80. Tian B, Al-Jamal WT, Al-Jamal KT, Kostarelos K. Doxorubicin-loaded lipid-quantum dot hybrids: Surface topography and release properties. International Journal of Pharmaceutics. 2011;doi: 10.1016/j.ijpharm.2011.01.057.
81. Wu W, Aiello M, Zhou T, Berliner A, Banerjee P, Zhou S. In-situ immobilization of quantum dots in polysaccharide-based nanogels for integration of optical pH-sensing, tumor cell imaging, and drug delivery. Biomaterials. 2010; 31: 3023-31. doi: 10.1016/j.biomaterials.2010.01.011.
82. Mathew ME, Mohan JC, Manzoor K, Nair SV, Tamura H, Jayakumar R. Folate conjugated carboxymethyl chitosan-manganese doped zinc sulphide nanoparticles for targeted drug delivery and imaging of cancer cells. Carbohydrate Polymers. 2010; 80: 442-8. doi: 10.1016/j.carbpol.2009.11.047.
83. Li J, Wu C, Gao F, Zhang R, Lv G, Fu D, et al. In vitro study of drug accumulation in cancer cells via specific association with CdS nanoparticles. Bioorganic & Medicinal Chemistry Letters. 2006; 16: 4808-12. doi: 10.1016/j.bmcl.2006.06.069.
84. Xu G, Yong K-T, Roy I, Mahajan SD, Ding H, Schwartz SA, et al. Bioconjugated Quantum Rods as Targeted Probes for Efficient Transmigration Across an in Vitro Blood−Brain Barrier. Bioconjugate Chem. 2008; 19: 1179-85.
85. Chen Z, Chen H, Meng H, Xing G, Gao X, Sun B, et al. Bio-distribution and metabolic paths of silica coated CdSeS quantum dots. Toxicology and Applied Pharmacology. 2008; 230: 364-71. doi: 10.1016/j.taap.2008.03.022.
86. Li KG, Chen JT, Bai SS, Wen X, Song SY, Yu Q, et al. Intracellular oxidative stress and cadmium ions release induce cytotoxicity of unmodified cadmium sulfide quantum dots. Toxicology in Vitro. 2009; 23: 1007-13. doi: 10.1016/j.tiv.2009.06.020.
87. Rzigalinski BA, Strobl JS. Cadmium-containing nanoparticles: Perspectives on pharmacology and toxicology of quantum dots. Toxicology and Applied Pharmacology. 2009; 238: 280-8. doi: 10.1016/j.taap.2009.04.010.
88. Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicology and Applied Pharmacology. 2008; 228: 200-11. doi: 10.1016/j.taap.2007.12.022.
89. Zhao Y, Lin K, Zhang W, Liu L. Quantum dots enhance Cu2+-induced hepatic L02 cells toxicity. Journal of Environmental Sciences. 2010; 22: 1987-92. doi: 10.1016/s1001-0742(09)60350-8.
90. Hezinger AFE, Teßmar J, Göpferich A. Polymer coating of quantum dots - A powerful tool toward diagnostics and sensorics. European Journal of Pharmaceutics and Biopharmaceutics. 2008; 68: 138-52. doi: 10.1016/j.ejpb.2007.05.013.
91. Edmund AR, Kambalapally S, Wilson TA, Nicolosi RJ. Encapsulation of cadmium selenide quantum dots using a self-assembling nanoemulsion (SANE) reduces their in vitro toxicity. Toxicology in Vitro. 2011; 25: 185-90. doi: 10.1016/j.tiv.2010.10.017.
92. Cho SJ, Maysinger D, Jain M, Roder B, Hackbarth S, Winnik FM. Long-Term Exposure to CdTe Quantum Dots Causes Functional Impairments in Live Cells. Langmuir. 2007; 23: 1974-80.
93. Su Y, He Y, Lu H, Sai L, Li Q, Li W, et al. The cytotoxicity of cadmium based, aqueous phase - Synthesized, quantum dots and its modulation by surface coating. Biomaterials. 2009; 30: 19-25.
94. Derfus AM, Chan WCW, Bhatia SN. Probing the Cytotoxicity of Semiconductor Quantum Dots. Nano Lett. 2004; 4: 11-8.
95. Yong K-T, Roy I, Swihart MT, Prasad PN. Multifunctional nanoparticles as biocompatible targeted probes for human cancer diagnosis and therapy. Journal of Materials Chemistry. 2009; 19: 4655-72.
96. Yong K-T, Ding H, Roy I, Law W-C, Bergey EJ, Maitra A, et al. Imaging Pancreatic Cancer Using Bioconjugated InP Quantum Dots. ACS Nano. 2009; 3: 502-10. doi:10.1021/nn8008933.